Summary Sixty-nine primary soft tissue tumours were examined for alterations of the RB1 gene which has previously been implicated in the genesis of retinoblastoma. In three tumours loss of both alleles of this gene (homozygous deletion) was detected. Two of these, both leiomyosarcomas, contained a chromosomal breakpoint within the RB1 gene, while in the third tumour, a radiation induced sarcoma, complete deletion was observed. Using a probe that detects a polymorphic locus within the RB1 gene we found loss of only one allele (heterozygous deletion) in 33% of soft tissue sarcomas examined, including two leiomyosarcomas, a malignant peripheral nerve sheath tumour, a rhabdomyosarcoma and a chondrosarcoma. When taken together our results suggest that alterations of the RB1 locus may play an important part in the pathogenesis of soft tissue tumours and particularly in leiomyosarcomas which accounted for four of the eight RB1 alterations observed in this study.
Iii recent years recombinant DNA technology has allowed i.solation and characterisation of some of the genes involved in tumour induction. Through study of transforming retroviruses and the use of the NIH3T3 mouse fibroblast transformation assay several dominantly acting oncogenes have been identified. These require an activating event in only one of the two alleles normally present in somatic cells to enable them to exert their transforming effect. By contrast there is a distinct group of recessive genes which require alterations of both alleles before they can contribute to tumour formation. In the latter group genetic alterations appear to result in loss of gene function and it is presumed that these genes normally act to suppress tumour formation. The paradigm for the recessive oncogenes is the gene at the RB locus on the long arm of chromosome 13, the loss of which has been implicated in the development of retinoblastoma.
Retinoblastoma is a paediatric embryonal tumour which may present in a familial or sporadic pattern. On the basis of the clinical and epidemiological characteristics of this tumour Knudson proposed a model of tumour induction requiring two hits or mutations (Knudson, 1971) . Patients with the familial form of the disease carry one hit in the germ line while individuals who develop the tumour in a sporadic fashion acquire both hits by somatic mutation. Characterisation of germline and tumour cell karyotypes led to the suggestion that these two notional hits represent deletion or inactivation of both alleles of a gene on the long arm of chromosome 13 (Yunis & Ramsey, 1978; BalabanMalenbaum et al., 1981; Benedict et al., 1983) . Recently this gene (RB1) has been cloned as a 4.7kb cDNA (Friend et al., 1986 ) and alterations in the form of deletions and point mutations have been detected in retinoblastoma specimens (Friend et al., 1986 (Friend et al., , 1987 Fung et al., 1987; Lee et al., 1987; Goddard et al., 1988; Dunn et al., 1988) .
The possibility that RB1 is involved in the development of other tumour types arises from the observation that patients with the familial form of the disease often develop second tumours several years after treatment of their retinoblastoma (Draper et al., 1986; Friend et al., 1987; DerKinderen et al., 1988) . These second tumours are most commonly osteosarcomas of bone but also include a variety of soft tissue tumours. Structural alterations of the RB1 gene have been detected in osteosarcomas (Friend et al., 1986 (Friend et al., , 1987 Fung et al., 1987) and, interestingly, in some tumour types not Correspondence: M.R. Stratton. Received 18 January 1989, and in revised form, 31 March 1989. commonly associated with the retinoblastoma trait such as breast carcinoma (T'Ang et al., 1988; Lee et al., 1988) and small cell carcinoma of the lung (Harbour et al., 1988 (Cooper et al., 1984) . Probes were radiolabelled using random primers (Feinberg & Vogelstein, 1983) . The probes used were the 4.7kb RB1 cDNA (divided into 0.9kb and 3.8kb fragments at an internal EcoRl site) (Fung et al., 1987) , p68RS2.0, a 2.0kb probe to the variable number of tandem repeat (VNTR) region of the RB1 gene from Dr T.
Dryja (Wiggs et al., 1988) , the g3 fingerprinting probe which detects sequences on chromosome 7 from Cellmark Diagnostics courtesy of Prof. A. Jeffreys (Wong et al., 1986) and 0.9kb Mspl fragment of the pEC plasmid acting as a probe to the VNTR region adjacent to the c-H-ras protooncogene on chromosome 11 (Capon et al., 1983) . For cytogenetic analysis, metaphases were Giemsa banded by conventional methods (Gallimore & Richardson, 1973) .
Results
Detection of homozygous deletions of the RBI gene Primary soft tissue tumours and cell lines were examined by Southern analysis using fragments derived from the 4.7kb RBl cDNA. The smaller of these, 0.9kb in size, detects 14.5, 5.8, 1.5 and 1.2kb HindIII bands while the 3.8kb probe detects 5.3, 4.5, 7.4, 9.4, 6.2 (Wiggs et al., 1988) , which allows each allele to be visualised independently (Figure 3 ). In the cases illustrated two bands, each corresponding to one allele of the RB1 gene, are seen in germline DNA (Figure 3, lanes 1 and 3) . However, in tumours from the respective patients (Figure 3 , lanes 2 and 4) only one of these bands is seen. Hence these cases have lost at least part of one RB1 allele during tumour development. Only cases in one unclassifiable case) showed abnormal band patterns (Figure 1) . In case I, a leiomyosarcoma, only the 14.5kb band detected by the 0.9kb RB1 probe remains. In case II, the unclassifiable tumour, the gene appears entirely deleted.
Residual signal in this tumour is due to contamination of the specimen by a population of stromal cells estimated at approximately 15% of the total by densitometry. In case III, a leiomyosarcoma, the band pattern generated by the 0.9kb probe is normal but several bands usually detected by the 3.8kb probe are absent. The nature of the deletions which give rise to these abnormal band patterns is illustrated in Figure 2, (Enzinger & Weiss, 1988) . The prevalence of individual histological types in our series of 69 primary tumours (Table I) is similar to that reported in the general population (Enzinger & Weiss, 1988) (Cavenee et al., 1983; Dryja et al., 1984; Hansen et al., 1985; Benedict et al., 1987; Toguchida et al., 1988 (Friend et al., 1987) three soft tissue tumours with homozygous RB1 deletions were found. One of these was also in a leiomyosarcoma, one in an MFH and the last case was unclassified. In this series only the unclassified tumour contained a breakpoint within the RB1 gene and heterozygous loss was not directly examined. Leiomyosarcomas have been reported as second tumours in patients with the familial form of retinoblastoma, but a wide range of other soft tissue tumours have also been described in this group (Draper et al., 1986; DerKinderen et al., 1988) .
Second tumours arising in zones of previous radiotherapy are well recognised in patients with familial retinoblastoma (Draper et al., 1986; DerKinderen et al., 1988) . The case of homozygous RBI deletion in a sarcoma originating from an irradiated area is therefore of particular interest. As far as can be ascertained this patient does not have constitutional abnormalities of the RB1 gene, nor is Hodgkin's disease a well recognised sequela of this condition. The karyotype of this tumour was grossly abnormal. Three related cell populations were present, each showing progressively more complex karyotypes with increase in ploidy. An interstitial deletion of the long arm of a chromosome 13, including part of the band (q14) to which the RB locus maps, was found in each line. The presence of the deletion on chromosome 13 in the near diploid cells indicates that this alteration may have occurred at an early stage in tumour development and it is therefore conceivable that loss of the RB1 gene itself resulted from the radiation insult.
Our results provide evidence that deletion of the RB1 gene is implicated in the pathogenesis of soft tissue tumours although the prevalence of detectable abnormalities is less than previously reported for retinoblastoma. Our findings also indicate that certain subgroups within the overall classification might be particularly susceptible to this form of genetic change and suggest that the RB1 gene may be a site of mutation following radiation treatment.
